PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease (AD) and other neurodegenerative diseases, have announced a new epigenetics collaboration with Sheffield Hallam University. This partnership will focus on ‘gene-based environmental biomarkers’, known...

Amneal Pharmaceuticals, Inc. have announced that it has entered into an exclusive licensing agreement with Zambon Biotech SA, part of the Zambon group, for IPX203 in the European Union, United Kingdom, and Switzerland. IPX203...

Dalip Sethi, Ph.D., Commercial Leader, Cell Therapy Technologies and Joy Duemke, Director of Marketing, North America, at Terumo Blood and Cell Technologies.  Until recently, even within the biopharma sphere, most people have not thought...

Telix has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radiopharmaceutical development and bioconjugation firm, based in Angleton, Texas. Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which...

Written by: Jerry Temko, Managing Director, In-House Counsel Group, Major, Lindsey & Africa. The huge potential of AI technology is no longer a topic confined to Silicon Valley startups or boardrooms at major tech companies...

SGD Pharma has achieved a gold medal in EcoVadis’ 2024 sustainability ratings. Building upon previous years, SGD Pharma’s score of 77 puts the business in the 98th percentile for manufacturers of glass and glass products....

Aptamer Group plc announces the second phase of its on-going partnership with Neuro-Bio, an Oxfordshire-based biotechnology company with a therapeutic focus on neurodegenerative disease, to develop Optimer binders for a lateral flow test for the...

Today’s healthcare market is overflowing with myriad products, making it increasingly difficult for businesses to stand out. This is particularly true for oral dosage forms, which – currently – account for over 80% of...

Grifols has announced that Biotest’s positive topline results from AdFIrst, its phase 3 clinical trial of its fibrinogen concentrate (FC), BT524, advance this potential treatment for acquired fibrinogen deficiency (AFD), an underserved growth market. The FC from...

PhaSER Biomedical (PhaSER) has received a grant totalling $2.3m to continue its pioneering work in accelerating drug discovery and development from the Bill & Melinda Gates Foundation. PhaSER will provide 8HUM transgenic mouse models,...

MIP Discovery has closed a £7m Series A financing round led by Mercia Ventures. Existing investor Calculus Capital also participated in the round, along with Angel investors.  The investment marks a pivotal change for MIP Discovery...

A team of academics from Aston University, the University of Nottingham and King’s College London has secured a £1.7m grant to engineer bioinspired artificial nanoparticles that can be used for oral drug delivery. Oral...

RSSL have announced plans to launch its new Innovation Hub, a dedicated platform to help small- and medium-sized biotech organisations de-risk and accelerate the development of cutting-edge products. RSSL’s Innovation Hub will be a supportive...

Refrigeration accounts for a high proportion of overall site energy costs, most notably cooling for pharmaceutical processes where up to 90% of energy costs can be accounted for by refrigeration. Ralph Howes, Cold Store Major...

BioAscent has opened its state-of-the-art protein production facility in an event officiated by Professor Michael Barrett OBE. The new facility marks the latest key investment the company has made, further strengthening its in-house drug...

French startup Bioptimus emerged from stealth following a seed funding round of $35M. Under the leadership of Professor Jean-Philippe Vert, PhD, Bioptimus unites a world-class team of scientists from Owkin and Google DeepMind alumni to transform...

NorthSea Therapeutics B.V. have announced the dosing of the first patient in its Phase 2a clinical trial of Orziloben (NST-6179) in intestinal failure-associated liver disease (IFALD), an orphan liver disease affecting individuals on prolonged intravenous (parenteral)...